TB drug study aims to Fine-Tune treatment dosing
NCT ID NCT02563327
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 30 times
Summary
This study looked at how two tuberculosis drugs, rifapentine and moxifloxacin, are processed in the body. Researchers took blood samples from 53 adults with TB to measure drug levels and see how they relate to treatment success and side effects. The goal is to improve dosing for future patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Joint Clinical Research Centre/ Makerere Univ Med Sch
Kampala, Uganda
-
National TB Program
Hanoi, Vietnam
-
University of Texas Health Science Center at
San Antonio, Texas, United States
Conditions
Explore the condition pages connected to this study.